Navigation Links
United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
Date:4/18/2013

SILVER SPRING, Md., April 18, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2013 financial results before market open on Thursday, April 25, 2013.

United Therapeutics will host a half-hour teleconference on Thursday, April 25, 2013, at 9:00 a.m. Eastern Time.  The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-855-859-2056, with international callers dialing 1-404-537-3406, and using conference code: 32040188.

This teleconference is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm.  [uthr-g]

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.


'/>"/>
SOURCE United Therapeutics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. National Honey Board Seeks Board Member Nominees: Appointments to be Made by United States Secretary of Agriculture
2. Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
3. Seven Outstanding Doctors Receive Honors From The United States & Canadian Academy of Pathology
4. United States Patent and Trademark Office to Require Signed NDA Affects Many Reports Wysebridge
5. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
6. United Therapeutics Announces Additional $420 Million Share Repurchase Program
7. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
8. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
9. United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012
10. United Therapeutics Corporation Reports Second Quarter 2012 Financial Results
11. New Approach to Growing Waste to Value Industry in United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2019)... OVERLAND PARK, Kan. (PRWEB) , ... October 15, ... ... rating to 23andMe, a leader among services that offer DNA Testing for health ... become so popular. Everywhere you look, it seems that people want to know ...
(Date:10/17/2019)... (PRWEB) , ... October 16, 2019 , ... ... provides personalized, easy-to-understand, web-based genetic counseling information, has published a new white paper ... year period and provides guidance as to how patients and medical providers can ...
(Date:10/15/2019)... ... ... ARPR , an award-winning tech PR agency at the epicenter of the future of ... of the Year in the Ragan’s Health Care PR & Marketing Awards. This award marks ... also revealed today that its healthIT practice group grew by 18 percent in Q3 this ...
(Date:10/10/2019)... ... 09, 2019 , ... The International Society for Pharmaceutical ... a newly-confirmed keynote speaker for the 2019 ISPE Annual Meeting & Expo ... Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally recognized clinical data ...
Breaking Biology Technology:
(Date:10/19/2019)... , ... October 18, 2019 , ... ... Applications of Lasers & Electro-Optics (ICALEO) was recently held in Orlando, Florida ... decision-makers from around the world, the event hosted dialogue with a deeper industry ...
(Date:10/19/2019)... (PRWEB) , ... October 18, 2019 , ... ... share their research, new ideas, and experience the best their field has to ... relating to life-science projects in industry and research. , Micro- and Nanopositioning Stages ...
(Date:10/17/2019)... ... October 15, 2019 , ... The scope of ... , Microbiology International currently manufactures ready-to-use culture broth and buffers in its proprietary ... & liquid supplements. , This major step underpins the company’s philosophy of offering ...
Breaking Biology News(10 mins):